An Open-Labelled PK-PD Study of ELORES in infections caused by ESBL producing gram-negative bacteria

Trial Profile

An Open-Labelled PK-PD Study of ELORES in infections caused by ESBL producing gram-negative bacteria

Completed
Phase of Trial: Phase I

Latest Information Update: 30 Aug 2016

At a glance

  • Drugs Ceftriaxone/disodium edetate/sulbactam (Primary)
  • Indications Gram-negative infections; Pneumonia; Sepsis; Urinary tract infections
  • Focus Pharmacodynamics; Pharmacokinetics
  • Sponsors Venus Remedies
  • Most Recent Events

    • 20 Aug 2013 Status changed from not yet recruiting to recruiting as reported by Clinical Trials Registry - India.
    • 01 Oct 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top